NCT02486289View on ClinicalTrials.gov

Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

April 30, 2016

Conditions
Mercury Poisoning
Interventions
DRUG

Emeramide

Mercury chelator NBMI ((N1,N3-bis(2-mercaptoethyl) isophthalamide)

DRUG

Placebo

NBMI Placebo

Trial Locations (1)

Unknown

Hospital Doctor Humberto Molina, Zaruma

Sponsors

Lead Sponsor

EmeraMed

Collaborators (1)

NBMI Science AB
All Listed Sponsors
collaborator

NBMI Science AB

UNKNOWN

lead

EmeraMed

INDUSTRY